Jerusalem Artichoke Fiber Shows Promise for Reversing Prediabetes in Clinical Trial
246-person study tested whether inulin fiber from Jerusalem artichokes could help prediabetic patients return to normal blood sugar levels.
Summary
This completed clinical trial investigated whether inulin fiber extracted from Jerusalem artichokes could help people with prediabetes return to normal blood sugar levels. The 24-week study enrolled 246 participants with prediabetes, randomly assigning them to receive either the Jerusalem artichoke fiber supplement or placebo. Researchers measured how many participants achieved normal blood glucose levels, along with improvements in insulin resistance and gut bacteria changes. The trial aimed to provide scientific evidence for preventing progression from prediabetes to full type 2 diabetes using natural dietary fiber interventions.
Detailed Summary
This multicenter clinical trial examined whether inulin-type fructose fiber extracted from Jerusalem artichokes could help people with prediabetes restore normal blood sugar levels and prevent progression to type 2 diabetes. The research focused on understanding how soluble dietary fiber intervention affects glucose metabolism and insulin resistance in at-risk populations.
The study employed a rigorous double-blind, placebo-controlled design spanning 24 weeks. Researchers enrolled 246 participants with confirmed prediabetes, randomly dividing them into experimental and control groups. The experimental group received NIUCHANG, a Jerusalem artichoke fiber supplement, while controls received matching placebo.
Primary measurements included the conversion rate from prediabetes to normal blood glucose levels, stable impaired glucose tolerance, or progression to type 2 diabetes. Secondary outcomes examined insulin resistance improvements and intestinal microbiome changes following fiber intervention. The trial ran from May 2016 to April 2018 and has completed data collection.
While specific results weren't detailed in available summaries, this research addresses a critical health optimization opportunity. Prediabetes affects millions globally and often progresses to type 2 diabetes without intervention. Jerusalem artichoke fiber represents a natural, potentially accessible approach to metabolic health improvement through gut microbiome modulation and enhanced glucose metabolism. The findings could inform evidence-based strategies for diabetes prevention using targeted dietary fiber supplementation, offering hope for those seeking natural approaches to metabolic health optimization.
Key Findings
- 24-week Jerusalem artichoke fiber intervention tested in 246 prediabetic participants
- Study measured conversion rates from prediabetes to normal blood glucose levels
- Secondary outcomes included insulin resistance and gut microbiome improvements
- Rigorous double-blind, placebo-controlled design strengthens evidence quality
Methodology
This was a multicenter, randomized, double-blind, placebo-controlled parallel trial enrolling 246 prediabetic participants. The intervention lasted 24 weeks, comparing Jerusalem artichoke inulin fiber against placebo. The study completed in April 2018 after nearly two years of data collection.
Study Limitations
Specific efficacy results are not yet publicly available despite trial completion. The study was sponsored by the supplement manufacturer, which could introduce bias. Generalizability may be limited to populations similar to the enrolled participants.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.